Free Trial

Corvus Pharmaceuticals (CRVS) Short Interest Ratio & Short Volume

Corvus Pharmaceuticals logo
$3.47 -0.16 (-4.41%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$3.46 -0.01 (-0.29%)
As of 08:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Corvus Pharmaceuticals Short Interest Data

Corvus Pharmaceuticals (CRVS) has a short interest of 5.77 million shares. This marks a 8.05% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.2, indicating that it would take 6.2 days of the average trading volume of 723,912 shares to cover all short positions.

Current Short Interest
5,770,000 shares
Previous Short Interest
5,340,000 shares
Change Vs. Previous Month
+8.05%
Dollar Volume Sold Short
$20.71 million
Short Interest Ratio
6.2 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
68,169,000 shares
Percentage of Shares Shorted
8.46%
Today's Trading Volume
547,212 shares
Average Trading Volume
723,912 shares
Today's Volume Vs. Average
76%
Short Selling Corvus Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CRVS Short Interest Over Time

CRVS Days to Cover Over Time

CRVS Percentage of Float Shorted Over Time

Corvus Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20255,770,000 shares $20.71 million +8.1%N/A6.2 $3.59
4/15/20255,340,000 shares $17.30 million +8.5%12.1%7.8 $3.24
3/31/20254,920,000 shares $15.65 million -8.7%11.1%7.9 $3.18
3/15/20255,390,000 shares $24.36 million +0.8%12.2%6.2 $4.52
2/28/20255,350,000 shares $21.61 million -6.6%12.1%5.8 $4.04
2/15/20255,730,000 shares $27.96 million -6.2%13.0%6.2 $4.88
1/31/20256,110,000 shares $32.75 million +11.1%N/A6.2 $5.36
1/15/20255,500,000 shares $27.06 million +1.3%N/A4.9 $4.92
12/31/20245,430,000 shares $29.05 million +26.0%N/A4.7 $5.35
12/15/20244,310,000 shares $31.81 million +22.8%N/A4 $7.38
11/30/20243,510,000 shares $31.91 million +6.4%N/A4.5 $9.09
11/15/20243,300,000 shares $27.03 million +12.6%N/A4.5 $8.19
10/31/20242,930,000 shares $25.90 million +20.1%N/A4.6 $8.84
10/15/20242,440,000 shares $16.40 million +13.5%N/A4.6 $6.72
9/30/20242,150,000 shares $11.35 million +31.1%N/A5.4 $5.28
9/15/20241,640,000 shares $8.36 million +14.7%N/A4.5 $5.10
8/31/20241,430,000 shares $6.41 million +4.4%N/A4.9 $4.48
8/15/20241,370,000 shares $5.21 million +19.1%N/A5.3 $3.80
7/31/20241,150,000 shares $2.96 million -8.0%N/A4.7 $2.57
7/15/20241,250,000 shares $2.50 million -12.6%N/A5.8 $2.00
6/30/20241,430,000 shares $2.60 million -4.7%N/A6.6 $1.82
6/15/20241,500,000 shares $3.06 million -1.3%N/A6.5 $2.04
5/31/20241,520,000 shares $3.28 million +17.8%N/A6.5 $2.16
5/15/20241,290,000 shares $2.86 million -5.2%N/A5.2 $2.22
4/30/20241,360,000 shares $2.11 million -0.7%3.7%5.4 $1.55
4/15/20241,370,000 shares $2.01 million -2.1%3.7%7 $1.47
3/31/20241,400,000 shares $2.49 million -6.0%3.8%6.6 $1.78
3/15/20241,490,000 shares $2.83 million +17.3%4.0%6.8 $1.90
2/29/20241,270,000 shares $2.84 million No Change3.4%5.7 $2.24
2/15/20241,270,000 shares $2.98 million -8.0%3.4%6.2 $2.35
1/31/20241,380,000 shares $2.76 million -1.4%3.7%6.3 $2.00
1/15/20241,400,000 shares $3.28 million +5.3%3.8%6 $2.34
12/31/20231,330,000 shares $2.34 million +2.3%3.6%6.1 $1.76
12/15/20231,300,000 shares $1.99 million -17.2%3.5%6.5 $1.53
11/30/20231,570,000 shares $2.40 million -12.3%4.3%7.9 $1.53
11/15/20231,790,000 shares $2.70 million +4.7%4.9%6.4 $1.51
10/31/20231,710,000 shares $1.93 million -3.4%4.6%6.4 $1.13
10/15/20231,770,000 shares $2.48 million No Change4.8%7.1 $1.40
9/30/20231,770,000 shares $2.58 million -2.8%4.8%6.1 $1.46
9/15/20231,820,000 shares $2.88 million +32.9%4.9%5 $1.58
July 2025 Rule Change to Impact Retirement Investors (Ad)

There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.

Yes, Send Me My FREE Retirement Guide
8/31/20231,370,000 shares $2.90 million +21.2%3.8%2.3 $2.12
8/15/20231,130,000 shares $2.44 million -2.6%3.1%1.8 $2.16
7/31/20231,160,000 shares $2.61 million -17.7%3.4%1.1 $2.25
7/15/20231,410,000 shares $3.47 million +11.9%4.1%1.3 $2.46
6/30/20231,260,000 shares $2.89 million +61.4%3.7%1.1 $2.29
6/15/2023780,600 shares $1.94 million -19.8%2.3%0.7 $2.49
5/31/2023973,100 shares $2.96 million +113.6%2.8%1.1 $3.04
5/15/2023455,500 shares $1.18 million +209.2%1.3%0.6 $2.60
4/30/2023147,300 shares $159,084.00 -38.3%0.4%0.6 $1.08
4/15/2023238,700 shares $248,248.00 +50.8%0.7%1.1 $1.04
3/31/2023158,300 shares $144,053.00 -20.9%0.5%0.8 $0.91
3/15/2023200,200 shares $144,144.00 +16.9%0.6%2.1 $0.72
2/28/2023171,200 shares $124,976.00 +35.9%0.5%1.4 $0.73
2/15/2023126,000 shares $97,007.40 +13.7%0.4%1 $0.77
1/31/2023110,800 shares $90,856.00 -34.9%0.3%0.8 $0.82
1/15/2023170,100 shares $154,791.00 -3.7%0.5%1.2 $0.91
12/30/2022176,700 shares $150,195.00 +17.3%0.5%1.2 $0.85
12/15/2022150,600 shares $126,353.40 -53.8%0.4%1 $0.84
11/30/2022325,900 shares $303,803.98 +58.1%0.9%2.2 $0.93
11/15/2022206,100 shares $187,963.20 -0.5%0.6%1.3 $0.91
10/31/2022207,100 shares $179,555.70 -12.4%0.6%1 $0.87
10/15/2022236,500 shares $215,215.00 +16.3%0.7%0.9 $0.91
9/30/2022203,300 shares $166,401.05 +1.6%0.6%0.7 $0.82
9/15/2022200,200 shares $191,191.00 +70.8%0.6%0.6 $0.96
8/31/2022117,200 shares $112,336.20 -64.5%0.3%0.4 $0.96
8/15/2022330,500 shares $371,812.50 -75.2%1.0%1.1 $1.13
7/31/20221,330,000 shares $1.17 million +70.1%3.9%4.7 $0.88
7/15/2022782,000 shares $774,962.00 -15.2%2.3%3.2 $0.99
6/30/2022922,500 shares $913,367.25 +306.2%2.7%3.6 $0.99
6/15/2022227,100 shares $224,806.29 +18.5%0.7%0.9 $0.99
5/31/2022191,600 shares $197,348.00 -22.9%0.6%0.8 $1.03
5/15/2022248,600 shares $258,544.00 +28.6%0.7%1 $1.04
4/30/2022193,300 shares $253,223.00 +5.2%0.6%0.8 $1.31
4/15/2022183,800 shares $266,510.00 -14.9%0.5%0.7 $1.45
3/31/2022215,900 shares $354,076.00 +5.2%0.6%0.7 $1.64
3/15/2022205,200 shares $299,592.00 +3.0%0.6%0.6 $1.46
2/28/2022199,200 shares $352,584.00 -41.3%0.6%0.5 $1.77
2/15/2022339,300 shares $692,172.00 +101.5%1.0%0.7 $2.04
1/31/2022168,400 shares $303,120.00 -43.8%0.5%0.3 $1.80
1/15/2022299,500 shares $673,875.00 +34.0%N/A0 $2.25
12/31/2021223,500 shares $538,635.00 -31.2%0.7%0.3 $2.41
12/15/2021324,700 shares $892,925.00 -43.0%1.0%0.2 $2.75
11/30/2021569,200 shares $1.94 million -45.8%1.9%0.1 $3.41
11/15/20211,050,000 shares $3.89 million -42.9%3.5%0.1 $3.70
10/29/20211,840,000 shares $8.34 million +3.4%6.2%0.2 $4.53
10/15/20211,780,000 shares $8.81 million -42.2%6.3%0.2 $4.95
9/30/20213,080,000 shares $14.91 million +318.7%10.9%0.4 $4.84
9/15/2021735,600 shares $1.68 million +45.0%2.5%0.1 $2.29
8/31/2021507,200 shares $1.15 million -48.0%1.8%2.1 $2.26
8/13/2021975,800 shares $1.93 million -22.6%3.5%4.4 $1.98
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
7/30/20211,260,000 shares $2.63 million +3.3%4.5%5.3 $2.09
7/15/20211,220,000 shares $2.84 million +0.8%3.7%4.1 $2.33
6/30/20211,210,000 shares $3.23 million +7.1%3.7%4.2 $2.67
6/15/20211,130,000 shares $3.10 million -8.9%3.4%3.5 $2.74
5/28/20211,240,000 shares $3.40 million +3.3%3.8%3.4 $2.74
5/14/20211,200,000 shares $2.95 million -9.1%N/A2.1 $2.46
4/30/20211,320,000 shares $3.72 million -1.5%N/A1.4 $2.82
4/15/20211,340,000 shares $3.79 million -7.6%N/A1.5 $2.83
3/31/20211,450,000 shares $4.26 million -8.2%N/A1.6 $2.94
3/15/20211,580,000 shares $5.10 million +24.4%N/A1.8 $3.23
2/26/20211,270,000 shares $4.55 million +2.4%N/A1.5 $3.58
2/12/20211,240,000 shares $4.89 million +0.8%N/A1.8 $3.94
1/29/20211,230,000 shares $4.54 million No Change5.7%5 $3.69
1/15/20211,230,000 shares $5.08 million +2.5%5.7%6.6 $4.13
12/31/20201,200,000 shares $4.52 million -3.2%5.6%6.8 $3.77
12/15/20201,240,000 shares $4.90 million -10.1%5.8%1.5 $3.95
11/30/20201,380,000 shares $5.56 million -0.7%6.4%1.6 $4.03
11/15/20201,390,000 shares $5.74 million -9.2%6.5%1.6 $4.13
10/30/20201,530,000 shares $6.10 million +2.7%7.1%1.7 $3.99
10/15/20201,490,000 shares $5.96 million +8.8%6.9%1.6 $4.00
9/30/20201,370,000 shares $5.49 million -14.4%6.4%1.3 $4.01
9/15/20201,600,000 shares $6.75 million -1.2%7.5%0.8 $4.22
8/31/20201,620,000 shares $6.14 million +2.5%7.6%0.8 $3.79
8/14/20201,580,000 shares $6.35 million -2.5%7.4%0.8 $4.02
7/31/20201,620,000 shares $6.87 million +25.6%7.6%0.8 $4.24
7/15/20201,290,000 shares $4.91 million +204.1%6.0%0.6 $3.81
6/30/2020424,200 shares $1.15 million +0.3%2.1%0.2 $2.72
6/15/2020422,900 shares $1.31 million +29.0%2.1%3.2 $3.10
5/29/2020327,800 shares $1.20 million -72.5%1.7%2.2 $3.66

CRVS Short Interest - Frequently Asked Questions

What is Corvus Pharmaceuticals' current short interest?

Short interest is the volume of Corvus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 5,770,000 shares of CRVS short. Learn More on Corvus Pharmaceuticals' current short interest.

What is a good short interest ratio for Corvus Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRVS shares currently have a short interest ratio of 6.0. Learn More on Corvus Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Corvus Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corvus Pharmaceuticals: Jane Street Group LLC, Millennium Management LLC, ADAR1 Capital Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Corvus Pharmaceuticals' short interest increasing or decreasing?

Corvus Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 5,770,000 shares, an increase of 8.1% from the previous total of 5,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Corvus Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Corvus Pharmaceuticals: Wave Life Sciences Ltd. (8.59%), Gyre Therapeutics, Inc. (13.99%), Phibro Animal Health Co. (4.52%), Mineralys Therapeutics, Inc. (16.91%), Collegium Pharmaceutical, Inc. (14.75%), Syndax Pharmaceuticals, Inc. (25.17%), Arcus Biosciences, Inc. (12.18%), Enliven Therapeutics, Inc. (21.79%), Avadel Pharmaceuticals plc (10.52%), Spyre Therapeutics, Inc. (24.50%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Corvus Pharmaceuticals stock?

Short selling CRVS is an investing strategy that aims to generate trading profit from Corvus Pharmaceuticals as its price is falling. CRVS shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Corvus Pharmaceuticals?

A short squeeze for Corvus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRVS, which in turn drives the price of the stock up even further.

How often is Corvus Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRVS, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:CRVS) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners